Skip to Content
MilliporeSigma
  • Hepatic angiomyolipoma with trace amounts of fat: a case report and literature review.

Hepatic angiomyolipoma with trace amounts of fat: a case report and literature review.

Journal of clinical pathology (2006-10-31)
S-N Wang, K-B Tsai, K-T Lee
ABSTRACT

Hepatic angiomyolipoma (AML), a rare benign mesenchymal tumour, is characterised by the presence of mature adipose tissue, smooth-muscle cells and thick-walled blood vessels. Increasing attention to hepatic AMLs has led to the discovery that sufficient proportions of fat often allow for definite diagnoses preoperatively. However, the proportion of fatty tissue in these tumours is highly variable. One case of hepatic AML is reported, where the amount of fat was <1%. In this case, the viral hepatitis markers, including hepatitis B antigen and anti-hepatitis C virus antibody, were negative. The serum alpha-fetoprotein level was 3.4 ng/ml and in the normal range. Abdominal ultrasonography showed a hypoechoic mass measuring 5 cm in diameter and without an obvious capsule in the left lobe of the liver. A dynamic computed tomography scan showed a well-defined and slightly enhanced mass in the medial segment of the left lobe of the liver. Angiography showed that the mass was hypervascular in character. As hepatocellular carcinoma was highly suspected from these preoperative image studies, a left lobectomy was carried out. Microscopically, the amount of fat was too low to establish a diagnosis of hepatic AML. However, positive homatropine methylbromide 45 immunoreactivity of the smooth-muscle cells seemed to assist in arriving at the diagnosis.

MATERIALS
Product Number
Brand
Product Description

Homatropine methylbromide for system suitability, European Pharmacopoeia (EP) Reference Standard
Homatropine methylbromide, European Pharmacopoeia (EP) Reference Standard